Our plans in this revised application for the Center for Neuroscience in Schizophrenia (CNS) represent a natural outgrowth of the collaborative interactions that exist within the large community of basic and clinical neuroscientists on campus. Given the heterogeneity of the schizophrenic syndrome and the lack of consensus regarding its pathogenesis, we believe that a diverse and multidisciplinary approach is the most appropriate conceptual perspective for relating neuroscience and schizophrenia. Consequently, the scientific areas of basic and clinical investigations proposed in this application deliberately include a wide range of topics and approaches to the study of brain function in animal and human subjects. The Center will consist of the Clinical Core; and four major research programs. The Clinical Core will undertake the recruitment, clinical assessment, management, maintenance, and follow-up of clinical and normal subjects required for current and future studies, including those associated with the Seed Money Program. It will, in addition, conduct neuropsychological, autoimmune, sleep, cognitive, and treatment investigations. The four key research programs proposed encompass neurophysiological studies of the alterations in the network properties of hippocampal neurons in rats, neuronanatomical studies of the prefrontal cortex in monkeys , neurophysiological studies of dopaminergic neurons and neurochemical studies of dopamine release in rat forebrain and clinical in vivo NMR assessment of structural and metabolic changes in the brains of schizophrenic patients. As might be expected, certain common themes run through the four programs. For example, a role for frontal cortical dysfunctions in the etiology of schizophrenia is presumed in Programs 2, 3, and 4 and the biological actions of typical and atypical neuroleptics are relevant to all four programs. Our greatest hope and reason for investment in this venture is in the participatory scientific and mutual educational activities between basic neuroscientists and clinical investigators that we see in a Center of this kind, and the emergence from such productive collaborative interactions of new hypotheses and modes for approaching these issues of joint concern, as well as the development of the next generations of investigators who will be sufficiently will trained and equipped to develop successful links between basic and clinical neuroscience relevant to major mental disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
1P50MH045156-01A1
Application #
3107312
Study Section
Special Emphasis Panel (SRCM (01))
Project Start
1990-04-01
Project End
1993-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Cai, HuaLin; Zhou, Xiang; Dougherty, George G et al. (2018) Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia. Psychoneuroendocrinology 90:43-51
Stevenson, J M; Reilly, J L; Harris, M S H et al. (2016) Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes. Transl Psychiatry 6:e739
Lizano, Paulo L; Keshavan, Matcheri S; Tandon, Neeraj et al. (2016) Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study. Schizophr Res 170:115-22
Bishop, Jeffrey R; Reilly, James L; Harris, Margret S H et al. (2015) Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia. Psychopharmacology (Berl) 232:145-54
Horton, Leslie E; Tarbox, Sarah I; Olino, Thomas M et al. (2015) Trajectories of premorbid childhood and adolescent functioning in schizophrenia-spectrum psychoses: A first-episode study. Psychiatry Res 227:339-46
Lencer, Rebekka; Bishop, Jeffrey R; Harris, Margret S H et al. (2014) Association of variants in DRD2 and GRM3 with motor and cognitive function in first-episode psychosis. Eur Arch Psychiatry Clin Neurosci 264:345-55
Hall, Nathan; Colby, Carol (2014) S-cone visual stimuli activate superior colliculus neurons in old world monkeys: implications for understanding blindsight. J Cogn Neurosci 26:1234-56
Subramanian, Janani; Colby, Carol L (2014) Shape selectivity and remapping in dorsal stream visual area LIP. J Neurophysiol 111:613-27
Berdyyeva, Tamara K; Olson, Carl R (2014) Intracortical microstimulation of supplementary eye field impairs ability of monkeys to make serially ordered saccades. J Neurophysiol 111:1529-40
Richard, Annette E; Carter, Cameron S; Cohen, Jonathan D et al. (2013) Persistence, diagnostic specificity and genetic liability for context-processing deficits in schizophrenia. Schizophr Res 147:75-80

Showing the most recent 10 out of 382 publications